Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. LFWD
LFWD logo

LFWD

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

LFWD News

Lifeward Announces 1-for-12 Reverse Stock Split

Feb 20 2026stocktwits

Oramed Pharmaceuticals and Lifeward Sign Strategic Deal, Investing $9 Million

Jan 13 2026NASDAQ.COM

Lifeward Appoints Bob Marshall as Chairman of the Board Effective January 1, 2026

Dec 19 2025Globenewswire

Lifeward Appoints Bob Marshall as Chairman of the Board Effective January 1, 2026

Dec 19 2025Newsfilter

Lifeward Partners with Verita Neuro to Expand ReWalk Market Access

Dec 17 2025Newsfilter

Lifeward Secures Humana Approval for ReWalk 7 Exoskeleton

Dec 03 2025Newsfilter

HC Wainwright & Co. Reaffirms Buy Rating on Lifeward, Adjusts Price Target to $4.5

Nov 18 2025Benzinga

Lifeward Scheduled to Announce Third Quarter Financial Results on November 14, 2025

Nov 10 2025Newsfilter

First Medicare Advantage Plan Offers Coverage for ReWalk 7 Personal Exoskeleton

Sep 09 2025Newsfilter

Lifeward Secures European Authorization for New ReWalk Exoskeleton

Sep 09 2025NASDAQ.COM

Lifeward Receives CE Mark Approval for the ReWalk 7 Personal Exoskeleton

Sep 08 2025Newsfilter

Lifeward Names Almog Adar as New CFO, Strengthening Executive Leadership

Aug 13 2025Newsfilter

Lifeward Names Almog Adar As CFO; Shares Rise 4% Pre-Market

Aug 13 2025NASDAQ.COM

Lifeward to Report Second Quarter Financial Results on August 14, 2025

Aug 07 2025Newsfilter

Lifeward Expands Distribution Partnership with SportsMed Ltd. to Add Coverage for United Arab Emirates and Entire Gulf Cooperation Council Region

Aug 04 2025Newsfilter

MedRhythms Appoints Larry Jasinski as Chief Executive Officer to Lead Next Phase of Growth and Commercial Expansion

Jul 07 2025Newsfilter